Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Haddad · SciRah

Researcher profile · Semantic Scholar

M. Haddad

Share profile

M. Haddad — researcher profile on SciRah

h-index: 17
Works: 47
Citations: 948

Most-cited papers

A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase
Trevor Hinkley, Joao Martins, C. Chappey, M. Haddad +4 more
2011Nature Genetics187 citations
Semantic Scholar
Exploring the Complexity of the HIV-1 Fitness Landscape
R. Kouyos, G. Leventhal, Trevor Hinkley, M. Haddad +3 more
2012PLoS Genetics114 citations Open access
Semantic Scholar
Feasibility analysis of a case-based reasoning system for automated detection of coronary heart disease from myocardial scintigrams
M. Haddad, K. Adlassnig, G. Porenta
1997Artif. Intell. Medicine68 citations
Semantic Scholar
HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer
A. Lipton, L. Goodman, K. Leitzel, Jennifer W. Cook +25 more
2013Breast Cancer Research and Treatment67 citations Open access
Semantic Scholar
Quantitative measurement of HER2 expression in breast cancers: comparison with ‘real-world’ routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival
D. Yardley, P. Kaufman, Weidong Huang, L. Krekow +17 more
2015Breast Cancer Research48 citations Open access
Semantic Scholar
Recombination Accelerates Adaptation on a Large-Scale Empirical Fitness Landscape in HIV-1
D. Moradigaravand, R. Kouyos, Trevor Hinkley, M. Haddad +3 more
2014PLoS Genetics46 citations Open access
Semantic Scholar
Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy.
R. Duchnowska, W. Biernat, B. Szostakiewicz, J. Sperinde +16 more
2012The Oncologist44 citations Open access
Semantic Scholar
Assessing Predicted HIV-1 Replicative Capacity in a Clinical Setting
R. Kouyos, V. von Wyl, Trevor Hinkley, C. Petropoulos +8 more
2011PLoS Pathogens44 citations Open access
Semantic Scholar
Quantitative Measurements of Tumoral p95HER2 Protein Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab: Independent Validation of the p95HER2 Clinical Cutoff
R. Duchnowska, J. Sperinde, A. Chenna, M. Haddad +16 more
2014Clinical Cancer Research38 citations Open access
Semantic Scholar
Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases.
R. Duchnowska, J. Sperinde, A. Chenna, Weidong Huang +16 more
2015Neuro-Oncology37 citations Open access
Semantic Scholar
Prevalence in the Usa of Rilpivirine Resistance-Associated Mutations in Clinical Samples and Effects on Phenotypic Susceptibility to Rilpivirine and Etravirine
G. Picchio, L. Rimsky, V. Van Eygen, M. Haddad +2 more
2014Antiviral Therapy36 citations
Semantic Scholar
Correlation of HER2, p95HER2 and HER3 Expression and Treatment Outcome of Lapatinib plus Capecitabine in her2-Positive Metastatic Breast Cancer
Sae-Won Han, Y. Cha, A. Paquet, Weidong Huang +12 more
2012PLoS ONE30 citations Open access
Semantic Scholar
A Decade of HIV-1 Drug Resistance in the United States: Trends and Characteristics in a Large Protease/Reverse Transcriptase and Co-Receptor Tropism Database from 2003 to 2012
A. Paquet, Owen D Solberg, L. Napolitano, J. Volpe +4 more
2014Antiviral Therapy29 citations Open access
Semantic Scholar
HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progression.
O. Ng, O. Laeyendecker, A. Redd, S. Munshaw +12 more
2014Journal of Infectious Diseases20 citations Open access
Semantic Scholar
Trends in HIV-1 Reverse Transcriptase Resistance-Associated Mutations and Antiretroviral Prescription Data from 2003–2010
Michael D. Miller, M. Haddad, C. Su, C. Gibbs +2 more
2012Antiviral Therapy20 citations Open access
Semantic Scholar
Short Communication Prevalence of Susceptibility to Etravirine by Genotype and Phenotype in Samples Received for Routine HIV Type 1 Resistance Testing in the United States
G. Picchio, J. Vingerhoets, L. Tambuyzer, E. Coakley +2 more
2011AIDS Research and Human Retroviruses19 citations
Semantic Scholar
Impact of reorientation algorithms on quantitative myocardial SPECT perfusion imaging.
M. Haddad, Gerold Porenta
1998Journal of Nuclear Medicine18 citations
Semantic Scholar
Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method
M. Evans, Phung Pham, A. Paquet, A. Parikh +3 more
2014BMC Bioinformatics15 citations Open access
Semantic Scholar
Estimating the Fitness Cost of Escape from HLA Presentation in HIV-1 Protease and Reverse Transcriptase
R. Mostowy, R. Kouyos, I. Hoof, Trevor Hinkley +5 more
2012PLoS Comput. Biol.14 citations Open access
Semantic Scholar
Automated assessment of dipyridamole 201Tl myocardial SPECT perfusion scintigraphy by case-based reasoning.
A. Khorsand, M. Haddad, S. Graf, D. Moertl +2 more
2001Journal of Nuclear Medicine11 citations
Semantic Scholar
Trends in Darunavir Resistance-Associated Mutations and Phenotypic Resistance in Commercially Tested United States Clinical Samples Between 2006 and 2012
E. Lathouwers, Soumi Gupta, M. Haddad, A. Paquet +2 more
2015AIDS Research and Human Retroviruses9 citations
Semantic Scholar
Principal component analysis of general patterns of HIV-1 replicative fitness in different drug environments.
Joao Martins, C. Chappey, M. Haddad, J. Whitcomb +3 more
2010Epidemics9 citations Open access
Semantic Scholar
Prevalence of genotypic and phenotypic susceptibility to etravirine in US samples received for routine resistance testing
G. Picchio, J. Vingerhoets, L. Tambuyzer, E. Coakley +2 more
20107 citations
Semantic Scholar
A Case-Based Reasoning System for Genotypic Prediction of HIV-1 Co-receptor tropism
M. Evans, A. Paquet, Wei Huang, L. Napolitano +8 more
2013J. Bioinform. Comput. Biol.5 citations Open access
Semantic Scholar
Predictive Biomarkers and Personalized Medicine Quantitative Measurements of Tumoral p 95 HER 2 Protein Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab : Independent Validation of the p 95 HER 2 Clinical Cutoff
R. Duchnowska, J. Sperinde, A. Chenna, M. Haddad +19 more
20143 citations
Semantic Scholar
Correlation of quantitative p95HER2 and HER2 protein expression with pathologic complete response (pCR) in HER2-positive breast cancer patients (pts) treated with neoadjuvant (NEO) trastuzumab-containing therapy.
J. Villasboas, J. Hurley, J. Weidler, A. Paquet +10 more
20123 citations
Semantic Scholar
Abstract 2010: Immunosignature technology detects stage I lung cancer from a drop of serum
T. Tarasow, M. Rowe, M. Haddad, K. Sykes
20152 citations
Semantic Scholar
Minimal sequence variability of the region of HIV-1 integrase targeted by the Abbott RealTime HIV-1 viral load assay in clinical specimens with reduced susceptibility to raltegravir.
Thomas P Young, L. Napolitano, A. Paquet, N. Parkin +5 more
2013Journal of Virological Methods2 citations
Semantic Scholar
Quantitative HER2 levels and steroid receptor expression in primary breast cancers and in matched brain metastases.
W. Biernat, R. Duchnowska, T. Trojanowski, T. Mandat +16 more
20122 citations
Semantic Scholar
Risk of Breast Cancer with CXCR4-using HIV Defined by V3-Loop Sequencing
J. Goedert, L. Swenson, L. Napolitano, M. Haddad +10 more
2015Journal of Acquired Immune Deficiency Syndromes1 citations Open access
Semantic Scholar
Abstract P6-11-07: Quantitative p95HER2 levels in primary breast cancers and in matched brain metastases
R. Duchnowska, J. Sperinde, A. Chenna, Weidong Huang +16 more
20131 citations
Semantic Scholar
Quantitative measurements of p95HER2 (p95) and total HER2 (H2T) protein expression in patients with trastuzumab-treated, metastatic breast cancer (MBC): Independent confirmation of clinical cutoffs.
Wojciech Biernat, R. Duchnowska, B. Szostakiewicz, Jeff Sperinde +15 more
2011Journal of Clinical Oncology1 citations
Semantic Scholar
Correlation between quantitative HER2 protein level and the risk of brain metastasis (BM) in patients (pts) with metastatic breast cancer (MBC) treated with trastuzumab-containing therapy.
R. Duchnowska, B. Szostakiewicz, T. Jankowski, B. Arłukowicz-Czartoryska +6 more
20101 citations
Semantic Scholar
Short communication A decade of HIV-1 drug resistance in the United States: trends and characteristics in a large
A. Paquet, Owen D Solberg, L. Napolitano, J. Volpe +4 more
20140 citations
Semantic Scholar
Quantitative measurements of p95HER2 (p95) protein expression in tumors from patients with metastatic breast cancer (MBC) treated with trastuzumab: Independent confirmation of the p95 clinical cutoff.
R. Duchnowska, J. Sperinde, M. Haddad, A. Chenna +16 more
20130 citations
Semantic Scholar
Cases of choroidal metastasis revealing lung cancer
M.-G. Barcatali, S. Miocque, M. Haddad, F. Mouriaux
20130 citations
Semantic Scholar
Correlation of quantitative p95HER2, HER2, and HER3 protein expression with pathologic complete response (pCR) in HER2-positive breast cancer patients (pts) treated with neoadjuvant chemotherapy and trastuzumab.
J. Villasboas, J. Hurley, J. Weidler, A. Paquet +10 more
2012Journal of Clinical Oncology0 citations
Semantic Scholar
Novel vomputational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies
M. Evans, A. Paquet, Phung Pham, A. Parikh +3 more
2012Retrovirology0 citations Open access
Semantic Scholar
Abstract P2-05-06: Quantitative measurement of HER2 expression in breast cancers: comparison with “real world” HER2 testing in a multi-center Collaborative Biomarker Study (CBS) and correlation with clinicopathological features
D. Yardley, P. Kaufman, J. Adams, L. Krekow +14 more
20120 citations
Semantic Scholar
Novel computational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies
Mcw Evans, A. Paquet, P. Phung, A. Parikh +3 more
2012Retrovirology0 citations Open access
Semantic Scholar
Abstract P2-10-31: Correlation of quantitative p95HER2 and total HER2 levels with clinical outcomes in a combined analysis of two cohorts of trastuzumab-treated metastatic breast cancer patients
R. Duchnowska, J. Sperinde, K. Leitzel, B. Szostakiewicz +22 more
20120 citations
Semantic Scholar
Quantitative HER2 measurement and PI3K mutation profile in matched primary and metastatic breast cancer tissues.
Weidong Huang, J. Lara, R. Michaelson, Xiu Sun +15 more
20120 citations Open access
Semantic Scholar
Abstract P2-10-16: Quantitative HER3 protein expression and PIK3CA mutation status in matched samples from primary and metastatic breast cancer tissues and correlation with time to recurrence
J. Sperinde, J. Lara, R. Michaelson, X. Sun +17 more
20120 citations
Semantic Scholar
P1-07-12: Assessment of Real World HER2 Status by Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) in Breast Cancers: Comparison with HERmark®, a Validated Quantitative Measure of HER2 Protein Expression.
Wei Huang, A. Paquet, S. Sivaraman, R. Pesano +9 more
20110 citations
Semantic Scholar
P2-12-05: Correlation between Quantitative HER2 Protein Expression and Risk of Brain Metastases in HER2−Positive Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy.
R. Duchnowska, Wojciech Biernat, B. Szostakiewicz, J. Sperinde +16 more
20110 citations
Semantic Scholar
Evolution of Recombination on an HIV-1 Derived Fitness Landscape
Joao Martins, R. Kouyos, Trevor Hinkley, C. Chappey +4 more
2010IEEE Symposium on Artificial Life0 citations
Semantic Scholar
Discordant HER2 Total and HER2 Homodimer Levels by HERmark Analysis in Matched Primary and Metastatic Breast Cancer FFPE Specimens.
K. Leitzel, P. Conte, V. Guarneri, E. Barbieri +8 more
20090 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Paquet×27
Invite
A. Paquet — researcher profile on SciRah
J. Weidler×21
Invite
J. Weidler — researcher profile on SciRah
C. Petropoulos×20
Invite
C. Petropoulos — researcher profile on SciRah
Yolanda S. Lie×20
Invite
Yolanda S. Lie — researcher profile on SciRah

×16

Invite

J. Sperinde — researcher profile on SciRah

Weidong Huang×16

Invite

Weidong Huang — researcher profile on SciRah

John W. Winslow×12

Invite

John W. Winslow — researcher profile on SciRah

R. Duchnowska×11

Invite

R. Duchnowska — researcher profile on SciRah

Invite

B. Radecka — researcher profile on SciRah

Invite

M. Bates — researcher profile on SciRah

Invite

J. Whitcomb — researcher profile on SciRah

Invite

A. Chenna — researcher profile on SciRah